Diagnosis of Hyperemesis Gravidarum
Hyperemesis gravidarum is diagnosed clinically using the Windsor definition: severe nausea and/or vomiting beginning before 16 weeks gestation, inability to eat and drink normally, and strongly limiting daily activities, with signs of dehydration considered contributory—not requiring specific weight loss thresholds or laboratory abnormalities. 1
Clinical Diagnostic Criteria
The diagnosis represents a paradigm shift away from rigid objective measures (like the traditional ≥5% weight loss requirement) toward patient-centered subjective criteria that improve recognition 1. The key diagnostic elements include:
History and Symptom Assessment
- Onset: Symptoms typically begin between 4-7 weeks gestation, peak around 9 weeks 1
- Severity: Severe nausea and/or vomiting (at least one must be severe)
- Functional impact: Inability to maintain normal oral intake and severe limitation of daily activities 1
- Timing: Symptoms must begin before 16 weeks gestation 1
Physical Examination Findings
- Dehydration signs: Contributory but not mandatory for diagnosis 1
- Weight loss: May be present but no longer required to meet diagnostic threshold 1
Validated Severity Scoring Tools
Use the PUQE score for mild-to-moderate cases to objectively quantify severity and monitor treatment response 1. However, recognize that PUQE is not valid for severe NVP and hyperemesis gravidarum 1.
For severe cases and confirmed HG, use the HELP score (available at hyperemesis.org/tools/help-score/) to track symptoms over time and assess treatment response 1.
Laboratory Investigations
Important caveat: Laboratory abnormalities support the diagnosis but are not required. When present, typical findings include 1:
Electrolyte and Metabolic Abnormalities
- Hyponatremia
- Hypokalemia
- Low serum urea
- Raised hematocrit
- Metabolic hypochloremic alkalosis (or metabolic acidosis if severe)
Thyroid Function
- Abnormal in two-thirds of HG cases 1
- Biochemical thyrotoxicosis: raised free T4 with suppressed or low TSH
- Due to structural similarity between hCG and TSH 1
- Critical point: These patients are clinically euthyroid, lack thyroid antibodies, and the abnormalities resolve as HG improves—antithyroid treatment is unnecessary 1
Liver Function
- Abnormal in up to 40% of cases 1
- Most commonly elevated transaminases
- Mild elevations in bilirubin and amylase may occur
- Resolves with HG improvement 1
Ketonuria
Do not use ketonuria to diagnose or assess severity—it is not associated with dehydration or HG severity 1. This is high-quality evidence (level 1++) that contradicts traditional practice.
Diagnostic Algorithm
- Confirm gestational age <16 weeks at symptom onset
- Assess severity using Windsor criteria (severe nausea/vomiting, inability to maintain oral intake, functional impairment)
- Apply validated scoring: PUQE for initial assessment; HELP score if severe
- Physical examination for dehydration signs
- Laboratory workup to assess complications and exclude other causes:
- Electrolytes, renal function
- Thyroid function (but do not treat biochemical thyrotoxicosis)
- Liver function tests
- Ignore ketonuria for diagnostic or severity assessment
- Exclude other causes through thorough history and targeted investigations 1
Common Pitfalls to Avoid
- Do not wait for ≥5% weight loss to diagnose HG—this delays recognition and treatment 1
- Do not use ketonuria as a diagnostic criterion or severity marker 1
- Do not treat biochemical thyrotoxicosis with antithyroid drugs in straightforward HG cases where the patient is responding to treatment 1
- Do not rely solely on objective measures—the patient's subjective experience and functional impairment are central to diagnosis 1
The diagnosis is ultimately clinical, based on the constellation of symptoms, functional impairment, and physical findings, with laboratory tests serving to assess severity of complications rather than establish the diagnosis itself 2, 3.